DBV Technologies

Equities

DBV

FR0010417345

Pharmaceuticals

Market Closed - Euronext Paris 11:35:07 2024-06-20 EDT After market 13:32:47
0.958 EUR -0.31% Intraday chart for DBV Technologies 0.955 -0.31%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading MT
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading MT
Transcript : DBV Technologies S.A. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading MT
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower MT
DBV Technologies Says ADS Ratio Change to be Effective June 7 MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading MT
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading MT
DBV Technologies: towards a change in ADS ratio CF
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3% MT
China confirms its awakening Our Logo
Mickey Mouse on Wall Street Our Logo
DBV Technologies: net loss widens in Q1 CF
DBV Technologies S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down MT
Chart DBV Technologies
More charts
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.961 EUR
Average target price
4.4 EUR
Spread / Average Target
+357.86%
Consensus